These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12088952)

  • 1. Sensitivity to vecuronium in seropositive and seronegative patients with myasthenia gravis.
    Itoh H; Shibata K; Nitta S
    Anesth Analg; 2002 Jul; 95(1):109-13, table of contents. PubMed ID: 12088952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difference in sensitivity to vecuronium between patients with ocular and generalized myasthenia gravis.
    Itoh H; Shibata K; Nitta S
    Br J Anaesth; 2001 Dec; 87(6):885-9. PubMed ID: 11878691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
    Stevens JB; Walker SC; Fontenot JP
    Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of use of pyridostigmine and requirement of vecuronium in patients with myasthenia gravis.
    Tripathi M; Kaushik S; Dubey P
    J Postgrad Med; 2003; 49(4):311-4; discussion 314-5. PubMed ID: 14699228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preanesthetic train-of-four fade predicts the atracurium requirement of myasthenia gravis patients.
    Mann R; Blobner M; Jelen-Esselborn S; Busley R; Werner C
    Anesthesiology; 2000 Aug; 93(2):346-50. PubMed ID: 10910480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the degree of sensitivity to nondepolarizing muscle relaxants related to requirements for postoperative ventilation in patients with myasthenia gravis?
    Kadoi Y; Hinohara H; Kunimoto F; Niijima A; Saito S; Goto F
    Anaesth Intensive Care; 2004 Jun; 32(3):346-50. PubMed ID: 15264728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rocuronium vs vecuronium for neuromuscular block during transsternal thymectomy in the patient with myasthenia gravis].
    Cordero Escobar I
    Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):578-82. PubMed ID: 22263401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular monitoring at the orbicularis oculi may overestimate the blockade in myasthenic patients.
    Itoh H; Shibata K; Yoshida M; Yamamoto K
    Anesthesiology; 2000 Nov; 93(5):1194-7. PubMed ID: 11046205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anesthesia and myasthenia gravis.
    Blichfeldt-Lauridsen L; Hansen BD
    Acta Anaesthesiol Scand; 2012 Jan; 56(1):17-22. PubMed ID: 22091897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
    Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the neuromuscular blocking effects of atracurium, mivacurium, and vecuronium on the adductor pollicis and the orbicularis oculi muscle in humans.
    Rimaniol JM; Dhonneur G; Sperry L; Duvaldestin P
    Anesth Analg; 1996 Oct; 83(4):808-13. PubMed ID: 8831326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seronegative myasthenia gravis associated with malignant thymoma.
    Richards J; Howard JF
    Neuromuscul Disord; 2017 May; 27(5):417-418. PubMed ID: 28238572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
    Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
    Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ephedrine fails to accelerate the onset of neuromuscular block by vecuronium.
    Komatsu R; Nagata O; Ozaki M; Sessler DI
    Anesth Analg; 2003 Aug; 97(2):480-483. PubMed ID: 12873939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vecuronium dose-response and maintenance requirements in patients with myasthenia gravis.
    Nilsson E; Meretoja OA
    Anesthesiology; 1990 Jul; 73(1):28-32. PubMed ID: 1972873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of halothane and sevoflurane on reversal of neuromuscular blockade induced by vecuronium in man].
    Izawa H; Takeda J; Fukushima K
    Masui; 1997 Feb; 46(2):177-83. PubMed ID: 9071099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latent myasthenia gravis revealed by protracted postoperative effect of non-depolarizing neuromuscular blockade.
    Ito S; Fujita Y; Sasano H; Sobue K
    J Anesth; 2012 Dec; 26(6):953-4. PubMed ID: 22710973
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison between sevoflurane and propofol neuromuscular effects in a patient with myasthenia gravis: effective doses of vecuronium.
    Itoh H; Shibata K
    Anesthesiology; 2001 Sep; 95(3):803-5. PubMed ID: 11575561
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to rocuronium and its determinants in patients with myasthenia gravis: A case-control study.
    Fujimoto M; Terasaki S; Nishi M; Yamamoto T
    Eur J Anaesthesiol; 2015 Oct; 32(10):672-80. PubMed ID: 26086278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromuscular blockade by vecuronium during induction with 5% sevoflurane or propofol.
    Nitahara K; Sugi Y; Kusumoto G; Shono S; Iwashita K; Higa K
    J Int Med Res; 2010; 38(6):1997-2003. PubMed ID: 21227003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.